A scientific presentation regarding JRM-001 is scheduled for the 36th Annual Meeting of the Japanese Society of Congenital Interventional Cardiology in Kawasaki, Japan | Metcela Inc.

A scientific presentation regarding JRM-001 is scheduled for the 36th Annual Meeting of the Japanese society of Congenital Interventional Cardiology (January 22-24, 2026) in Kawasaki, Japan.

January 23, 2026, 10:05–11:25 a.m. | Room A (Kawasaki City Industrial Promotion Hall)

Intracoronary Infusion of Cardiac Stem Cells in Single Ventricle Physiology -Resumption and first case of a Phase III trial-
Yusuke Shigemitsu¹, Kenji Baba¹, Maiko Kondo¹, Yosuke Fukushima¹, Yuya Kawamoto¹, Mayuko Hara¹, Koki Mitogawa¹, Shingo Kasahara²

¹ Department of Pediatrics, Okayama University Hospital
² Department of Cardiovascular Surgery, Okayama University Hospital

A scientific presentation regarding JRM-001 is scheduled for the 36th Annual Meeting of the Japanese Society of Congenital Interventional Cardiology in Kawasaki, Japan | Metcela Inc.

A scientific presentation regarding JRM-001 is scheduled for the 36th Annual Meeting of the Japanese Society of Congenital Interventional Cardiology in Kawasaki, Japan

An interview with our CEO, Kohtaro Toda, has been published in Nikkei Biotechnology & Business Online (in Japanese)

Our CEO, Kohtaro Toda, will present “The Realities of Utilizing a CDMO” at the J-TEC CDMO Seminar (in Japanese)

Metcela Resumes Phase 3 Clinical Trials of Cell Product JRM-001 for Patients with Functional Single Ventricle